Euro-Asian Interventional Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 8.23%
(FY 2022)
- Ebitda 9.14%
(FY 2022)
- Net Worth -43.71%
(FY 2022)
- Total Assets -0.35%
(FY 2022)
About Euro-Asian Interventional Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Daksha Bohora and Amit Bohora serve as directors at the Company.
- CIN/LLPIN
U33110GJ2010PTC060813
- Company No.
060813
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Euro-Asian Interventional Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daksha Bohora  | Director | 21-Aug-2014 | Current |
| Amit Bohora | Director | 15-Nov-2013 | Current |
Financial Performance and Corporate Structure Insights of Euro-Asian Interventional Technologies.
Euro-Asian Interventional Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 8.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Euro-Asian Interventional Technologies?
In 2022, Euro-Asian Interventional Technologies had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bio India Interventional Technologies Private LimitedActive 16 years 11 monthsAmit Bohora is a mutual person
- Planet Corporate Awards Private LimitedActive 11 years 2 months
Daksha Bohora and Amit Bohora are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Euro-Asian Interventional Technologies?
Unlock and access historical data on people associated with Euro-Asian Interventional Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euro-Asian Interventional Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euro-Asian Interventional Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
